OraSure Technologies Inc 2025 SR
The report highlights OraSure Technologies' strategic transformation and its commitment to social and environmental responsibility. Significant milestones include the WHO prequalification of the first hepatitis C self-test and the acquisition of Sherlock Biosciences to enhance its molecular diagnostics portfolio. The company demonstrated progress in sustainability by reducing Scope 1 and 2 emissions and introducing eco-friendly packaging for HIV self-tests. Furthermore, OTI achieved high levels of diversity, with women comprising 55% of management and 42.9% of the board, while maintaining a strong focus on workplace safety and employee development.
Company: OraSure Technologies Inc
Sector: Health Care
Country: United States
Year: 2025
Type: SR
Pages: 32
OraSure Technologies Inc
Impact And Governance Report
The report highlights OraSure Technologies' strategic transformation and its commitment to social and environmental responsibility. Significant milestones include the WHO prequalification of the first hepatitis C self-test and the acquisition of Sherlock Biosciences to enhance its molecular diagnostics portfolio. The company demonstrated progress in sustainability by reducing Scope 1 and 2 emissions and introducing eco-friendly packaging for HIV self-tests. Furthermore, OTI achieved high levels of diversity, with women comprising 55% of management and 42.9% of the board, while maintaining a strong focus on workplace safety and employee development.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Women on Board
Women in Management